26
Jul
Jul
Medical Patent News
The Brazilian group Interdisciplinary AIDS Association, or ABIA, has joined Indian patient advocacy groups to oppose a patent application for Gilead Science’s antiretroviral drug Tenofovir, saying that the patent would have a direct impact width=396 align=left vspace=5 border=0>This article is republished with kind permission from our friends at The Kaiser Family Foundation. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery of in-depth coverage of health policy developments, debates and discussions. The Kaiser Daily Health Policy Report is published for Kaisernetwork.org, a free service of The Henry J. Kaiser Family Foundation. Copyright 2008 Advisory Board Company and Kaiser Family Foundation. All rights reserved.
This entry was posted
on Saturday, July 26th, 2008 at 12:16 am and is filed under Patent News.
You can follow any responses to this entry through the RSS 2.0 feed.
You can leave a response, or TrackBack URI from your own site.